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Abstract
Background: The clinical environment in which health care providers have to work everyday is highly complex;
this increases the risk for the occurrence of unintended events. The aim of this randomised controlled trial is to
improve patient safety for a vulnerable group of patients that have to go through a complex care chain, namely
elderly hip fracture patients.
Methods/design: A randomised controlled trial that consists of three interventions; these will be implemented in
three surgical wards in Dutch hospitals. One surgical ward in another hospital will be the control group. The first
intervention is aimed at improving communication between care providers using the SBAR communication tool.
The second intervention is directed at stimulating the role of the patient within the care process with a patient
safety card. The third intervention consists of a leaflet for patients with information on the most common
complications for the period after discharge. The primary outcome measures in this study are the incidence of
complications and adverse events, mortality rate within six months after discharge and functional mobility six
months after discharge. Secondary outcome measures are length of hospital stay, quality and completeness of
information transfer and patient satisfaction with the instruments.
Discussion: The results will give insight into the nature and scale of complications and adverse events that occur
in elderly hip fracture patients. Also, the implementation of three interventions aimed at improving the
communication and information transfer provides valuable possibilities for improving patient safety in this
increasing patient group. This study combines the use of three interventions, which is an innovative aspect of the
study.
Trial registration: The Netherlands National Trial Register NTR1562
Background
In many Western countries the population is ageing
rapidly. This change in population demographics makes
the necessary adjustments in healthcare needs and
requirements for this group an increasingly important
issue in research and policy [1]. Besides the expected
shortages in healthcare staff, the specific clinical chal-
lenges that have to be dealt with in elderly patients are
important. Elderly patients often do not show typical
signs and symptoms of a disease, thus making a timely
and accurate diagnosis more difficult [2]. In addition,
these patients are often suffering from substantial co-
morbidity, which further complicates the treatment.
In accordance with the changing demographics of the
general population, the incidence of hip fractures will
also increase in the upcoming years [3]. Hip fracture
patients represent a clinical management challenge; they
are an increasing group of predominantly older persons
with a variety of medical co-morbidities under varying
levels of control. In addition, they are facing operative
repair of the fracture and frequently a difficult post-
operative rehabilitation [4]. Even after this long rehabili-
tation, only half of these patients will return to their
community and only about a third regains their former
level of function [5,6]. Research has shown that hip-
fractures are associated with an one-year mortality
as high as 14 to 36% [6]. Also, the treatment of a hip
fracture is very expensive [7].
The care process for hip fracture patients has been clas-
sified as highly complex. To illustrate the multidisciplinary
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showed that hip fracture patients initially meet doctors,
nurses and other staff in the Emergency Department (ED),
radiology, surgery, geriatrics, anaesthesiology, the operat-
ing room, and sometimes the Intensive Care Unit (ICU)
[8]. The involvement of many different specialties makes
optimal communication, hand-offs and information trans-
fer even more important. To minimise the risk of compli-
cations, a complex series of interventions is required,
several physician specialties and hospital departments
need to be coordinated, and time is of the essence. Unfor-
tunately, this level of coordination seems difficult to
achieve [4]. Structuring the information transfer and com-
munication can be an important step in this process.
The study we describe in this protocol focuses on the
effects of improving the quality and safety of hip frac-
ture patients by structuring the information transfer and
interprofessional communication. An intervention study
is set up to implement three interventions in a com-
bined manner and is aimed at 1) improving the clinical
communication between care providers with the intro-
duction of the SBAR-communication tool, 2) strength-
ening the role of patients and their families with a
patient safety pocket card and 3) providing patients and
their families with specified information for the period
after discharge by handing out a leaflet which describes
the most common complications and who to contact
with specific questions. One of the goals of this study is
to establish whether this combined intervention pro-
gramme can result in a reduction of the complication
and adverse event (AE) rate in elderly hip fracture
patients.
A complication is an unintended and unwanted event
or state during or following medical specialist treatment,
that has an unfavourable effect on the health of the
patient to such an extend that adjustment of the medi-
cal treatment is necessary or that irreparable harm has
occurred [9]. An Adverse Event (AE) is defined as an
unintended injury that results in temporary or perma-
nent disability, death or prolonged hospital stay, and is
caused by healthcare management rather than by the
patient’s underlying disease process [10-13]. De Vries
et al. (2008) recently conducted a systematic review
based on eight patient record review studies to calculate
the mean overall incidence of in-hospital AEs. They sta-
ted that in 9.2% of all hospital admissions one or more
AEs occurred. Of these AEs nearly half (43.5%) were
preventable and 7.4% contributed to death [14]. Other
research showed that elderly patients are at increased
risk of suffering from Adverse AEs [15,16]. To our
knowledge, there is no published material on the AE
rate in elderly hip fracture patients yet.
AEs are generally caused by a combination of factors.
These often involve organisational, human, technical
and patient-related factors [17,18]. One of the contribut-
ing human-related factors are communication failures
[19], they are estimated to be of major influence in
60-70% of serious incidents [20-22]. There are many
barriers that can potentially contribute to communica-
tion difficulties between clinicians. Some examples are: a
lack of structure, differences in communication styles
and uncertainty about who is responsible for the
patient’s care [23-25]. Several tools have been developed
to structure the communication between care providers.
One of these is called SBAR, a situational briefing tool
developed by Kaiser Permanente [19,24]. SBAR stands
for Situation, Background, Assessment, Recommendation
and serves as a model that care providers can use to
structure clinical communication. So far, to our knowl-
edge, only a limited amount of published work exists on
the effectiveness of the SBAR-tool on improving clinical
communication [22,24]. The SBAR-tool could have the
potential to improve communication between care provi-
ders about patients when effective in the clinical setting,
so further evidence is needed. This can benefit the care
for our complex patient group where a timely and accu-
rate transfer of information is essential.
Another important factor for patient safety is improv-
ing the communication between care-providers and
patients. Previous findings provide some support for the
view that patients are willing to be more involved when
it comes to reducing patient safety incidents [26]. How-
ever, some research has also shown that this need for
patient involvement varies for several demographic vari-
ables, such as age. Younger patients tend to want more
involvement than older patients. [26-29]. It can there-
fore be useful to stimulate elderly patients to get more
actively involved in their own care process as they are
the only one to be involved in the care process from
beginning to end. Of course, an important question is to
what extend elderly patients actually want to be involved
and whether they feel comfortable enough to actively
question the (safety) practices of health care staff. It is
also important that patients should never feel responsi-
ble for the safety of the care they receive.
A third issue related to the previous two is the lack of
information that patients can experience, especially dur-
ing and after discharge. Smit et al. (2005) showed that
patients, in their own opinion, do not receive enough
information on what they have to do in an emergency
situation, how to use several medications together and
what they are allowed to do after discharge [30]. Often,
patients are discharged from hospital and come back to
the outpatient clinic after a scheduled amount of time.
In between, it is not always clear to them who to turn
to with questions following the hospital admission. An
adequate and timely transfer of information about the
hospital admission towards the general practitioner (GP)
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informed about the current medical condition of the
patient [31,32]. This lack of information transfer can
make it difficult to contact the appropriate care provider
with specific questions, even though early detection and
treatment of possible problems are very important.
Aim and research questions
The aim of this randomised controlled trial (RCT) is to
evaluate the effectiveness of a patient safety intervention
programme for elderly hip fracture patients. Therefore,
the following research questions will be addressed:
1. What is the nature and scale of adverse events
and avoidable harm in the care chain for elderly hip
fracture patients?
2. How is it, in the total care chain of elderly hip
fracture patients, possible to reduce risks and unin-
tended harm, and to ensure that complex care pro-
cesses proceed more safely? This research question
is divided into sub-questions for the three
interventions:
a What is the effectiveness of the SBAR commu-
nication tool on unintended events and avoidable
harm during hospital stay? (Intervention A)
b What is the effectiveness of a patient safety
card with guidelines for patients and their
families on signalling errors and patient trust in
health care? (Intervention B)
c What is the effectiveness of evidence based
bundles with regard to unintended events in the
period after discharge? (Intervention C)
Methods/Design
Study design
This RCT is set up as a multi-centre intervention
study in which hip fracture patients aged 65 years and
older will be included. Surgical wards of three hospi-
tals will participate in the intervention groups; one
surgical ward in another hospital will serve as a con-
trol group. The patients in the control group receive
care as usual. A baseline measurement using a retro-
spective record review study will be conducted. In the
following RCT the effects of three different interven-
tions will be compared to usual care, randomisation is
at patient level. Within the three intervention wards
patients are randomly assigned to one of four inter-
vention groups. The groups will receive the following
interventions:
￿ Group 1: use of SBAR communication tool for
nurses in the surgical wards
￿ Group 2: SBAR and patient safety card
￿ Group 3: SBAR and information leaflet (bundles)
for after discharge
￿ Group 4: SBAR, patient safety card and informa-
tion leaflet (bundles) for after discharge
During the study period the morning rounds will be
observed once a month in each intervention ward to
look at the information transfer and communication
between care providers. Two weeks and six months
after discharge patients will be interviewed about their
recovery and the added value of the interventions. Six
months after discharge the records of the included
patients will be reviewed to detect possible adverse
events and unintended harm. Figure 1 gives an overview
of the inclusion and data collection.
Definitions
The definitions used in this study were adopted from
previous international studies [9-11,13,33-37], Table 1
gives an overview of the used definitions.
Informed Consent and Ethical approval
Eligible patients receive an Informed Consent form with
information about the study as soon as possible after
admission. Participation in the study is voluntary.
P a t i e n t sa r eo n l yi n c l u d e di nt h es t u d ya f t e rb e i n g
informed about all the aspects of the study and giving
their consent to participate. The signed Informed Con-
sent form will be returned to the researchers to allow
further contact during the study. Patients are explicitly
informed about the fact that they can terminate their
participation in the study at any time without a specific
reason and without any negative consequences for
future medical treatment. Participants also have the
opportunity to consult a physician not involved in the
study with questions.
The privacy of the participating patients will be pro-
tected; data will be kept separated from patient names.
All confidential information will be treated according to
the medical confidentiality rules. Each patient will have
a specific research code that is not directly traceable to
a patient name; these codes are only available to the
study researchers. Data related to the study will be
stored on a protected server and can only be accessed
by authorised members of the research team.
The study protocol is approved by the Medical Ethical
Committee of the VU university medical center in
Amsterdam.
Participating surgical wards
Because the researchers will frequently have to visit the
participating surgical wards during the study, one hospi-
t a lr e g i o ni nt h eN e t h e r l a n d sw i l lb ec h o s e nf o rt h e
recruitment. Although the treatment for hip fractures is
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include a surgical ward of each of the three hospital
types that exist in the Netherlands; a university, a ter-
tiary medical teaching and a general hospital. A fourth
surgical ward in another hospital will be included as a
control group. An inclusion criterion for the surgical
wards is that they have to treat at least 100 elderly
patients with a hip fracture each year. The wards will be
recruited by informing already existing contacts within
the wards about the study. If the ward agrees to partici-
pate an official intake by the researchers will follow. The
nurses in the participating wards will be informed about
the study during a meeting. In this meeting the inter-
ventions and the inclusion process will be explained. For
each ward background information will be gathered
about the number of patients, treatment procedures and
discharge planning. This will make it possible to com-
pare the wards and correct for important differences.
Participants
The following inclusion criteria will be used to select
eligible patients for participation in the study:
￿ The patient is acutely admitted to the surgical
ward with a hip fracture during the research period;
￿ The patient is not admitted with polytrauma;
￿ The hip fracture is not a pathological fracture;
￿ The patient is 65 years of age or older;
￿ The patient will be operated on the hip fracture;
￿ The patient does not participate in an interfering
study;
￿ The patient is in a good cognitive condition to
fully understand the information about the study
and to give Informed Consent.
Patients will be recruited as quickly as possible after
admission to the hospital. The patients will be included
by the nurses working in de wards, this process will be
closely monitored by the researchers. When a patient is
eligible for participation the study will be explained to
them and Informed Consent will be asked. If the inclu-
sion by the nurses does not work out as intended, the
researchers will have to take over this part of the data
collection.
Randomisation
In this study surgical wards in three different interven-
tion hospitals and one surgical ward in a control hospi-
tal will participate. The eligible patients in the
intervention wards will be randomly assigned to one of
four intervention groups. Since the SBAR tool cannot be
randomised on patient level due to practical reasons,
this intervention will concern all patients in the inter-
vention wards. Before the start of the inclusion all
Acute admissions of patients with a hip fracture 
in the intervention wards
Inclusion criteria:
- 65 years or older
- Patient is operated on the hip fracture
- Patient is in a good cognitive condition
Exclusion criteria:
- Pathological fractures
- Patient participates in other RCT
- Polytrauma
Inclusion of participants:
- Determine to what group the patient is 
randomised
- Explain study to patient and ask for written 
informed consent
- Hand out the patient safety card when 
applicable with an explanation
- Fill out questionnaire with patient 
characteristics and pre-fracture functional 
status
Before discharge:
- Fill out questionnaire with status before 
discharge
- Asses the specific possible risks for the 
patient after discharge
- Hand out, when applicable, the leaflet with 
information for the period after discharge
- Register the location and telephone number 
where the patient can be contacted for  the 
telephone interview after discharge
Two weeks after discharge:
- Telephone interview to assess:   
o Functional status
o Possible problems or complications
o Use and value of interventions when 
applicable
o Patient trust in health care
Six months after discharge:
- Telephone interview to assess:
o Functional status
o Possible problems or complications
- Retrospective patient record review study to 
assess: 
o Possible complications and unintended 
events
o Adequacy and completeness of record 
keeping 
Figure 1 Flow-chart of patient inclusion and data-collection.
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be assigned a unique study number. The study numbers
are equally divided over four intervention groups, to
ensure equal group sizes as much as possible. All mate-
rials for each individual number will be gathered and
put into an envelope; the stack of envelopes will be kept
in the ward in consecutive order of the study numbers.
Each time an eligible patient can be asked to participate,
the first envelope of the stack will be used. The process
of randomisation is also shown in Figure 2.
Blinding
In this trial blinding of the patients is not possible as
they either do or do not receive the material belonging
to the interventions, and are therefore automatically
aware of the intervention group. Since the physicians
will not be directly involved in the inclusion of patients
t h e ya r eu n a w a r eo ft h ei n t e r v e n t i o ng r o u pap a t i e n t s
belongs to. For the assessment of the outcomes during a
telephone interview two weeks after discharge the inter-
viewer will be aware of the intervention group a patient
belongs to because specific additional questions for each
intervention group will be asked to evaluate the inter-
ventions. However, the interviewer will not be informed
about the background, research questions and outcome
measures of this study. For the telephone interview six
months after discharge the interviewer will be unaware
of the intervention group that the patient belongs to.
Finally, the reviewers in the retrospective record review
study will be blinded, they will assess some of the out-
come measures and should therefore be unaware of the
interventions that a patient might or might not have
received to prevent possible biases in their assessment.
Baseline measurement (Research question 1)
Aim
T h ea i mo ft h eb a s e l i n em e a surement is to determine
the nature and scale of unintended events in elderly
patients with a hip fracture. In addition, the reviewers
will also evaluate the quality of the record keeping and
the completeness of the transfer of information in the
patient record. This information will be used as a
Table 1 Definitions
An adverse event is an unintended injury that results in temporary or
permanent disability, death or prolonged hospital stay and that is
caused by health care management rather than by the patient’s
underlying disease process.
A complication is an unintended and unwanted event or state during
or following medical specialist treatment, that has an unfavourable
effect on the health of the patient to such an extend that adjustment
of the medical treatment is necessary or that irreparable harm has
occurred.
A near miss is defined as an act of commission or omission that could
have harmed the patient but was prevented from completion through
a planned or unplanned recovery.
Disability refers to temporary or permanent impairment of physical or
mental function attributable to the adverse event (including prolonged
or strengthened treatment, prolonged hospital stay, readmission,
subsequent hospitalisation, extra outpatient department consultations
or death).
Causation refers to injury caused by health care management
including acts of omission (inactions) i.e. failure to diagnose or treat,
and acts of commission (affirmative actions) i.e. incorrect diagnosis or
treatment, or poor performance.
Health Care management includes the actions of individual hospital
staff as well as the broader systems and care processes. Health care
management is any care related activity that involves the delivery of
care or monitoring of health which is provided by individuals or a team
of professionals.
A preventable adverse event is an adverse event resulting from an
error in management due to failure to follow accepted practice at an
individual or system level. Accepted practice was taken to be ‘the
current level of expected performance for the average practitioner or
system that manages the condition in question’.
Control group: 1 ward,
80 pts
80 pts: no 
interventions
4 wards, 400 patients 
(pts)
Intervention group: 3 wards, 320 
pts: SBAR, randomisation on 
patient level
80 pts:    
only       
SBAR
80 pts: SBAR
and Bundles
80 pts: SBAR
and Safety  
Card
80 pts: SBAR,
Safety Card and
Bundles
Figure 2 Flow-chart of randomisation procedure.
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study.
Background
Retrospective patient record review is a method that has
been used to study AEs in hospitals in several countries
[10,13,38]. The methods and review form used in this
study will be based on the Dutch Adverse Event Study
[34,39]. They used a method that was based on a proto-
col originally developed by the Harvard Medical Practice
Study, which studied the incidence of AEs in New York
State hospitals in 1984 [38].
Method
The incidence of complications and AEs will be mea-
sured within the care chain and especially during the
hospital admission of elderly hip fracture patients. In
t h i ss t u d yw el o o ka tt h ec a r ec h a i nf r o mt h em o m e n t
that the patient is brought into the emergency depart-
ment until six months after discharge from the hospital.
Therefore the patients’ hospital record will be studied in
retrospect by an experienced surgeon. For the baseline
measurement patient records of hip fracture patients
acutely admitted in 2007, the year previous to the start
of the intervention study, will be reviewed using a struc-
tured review form. In each hospital all surgical and
orthopaedic admissions of patients with a hip fracture of
65 years or older will be selected. Of these selected
index admissions the medical, nursing and, if existing,
the outpatient records will be collected, the X-rays
made during the admission will also be available.
Records of patients with a pathological fracture, poly-
trauma or elective admission will be excluded. The main
outcome variables in this part of the study are: rate of
complications, adverse events, near misses and informa-
tion transfer between care providers.
T h ep a t i e n tr e c o r d sw i l lb er e v i e w e db yat e a mo f
eight experienced reviewers. The selection criteria for
the reviewers are:
￿ At least ten years post graduate clinical (surgical)
experience;
￿ Surgical experience with hip fractures;
￿ Good reputation among colleagues;
￿ No longer than 8 years retired at the start of the
study;
￿ Experience or affinity with analysis of incidents,
complaints and errors.
Most of the reviewers have participated in a previous
record review study [39] and therefore are already famil-
iar with this type of research, terminology and metho-
dology. Nevertheless, they will all follow a half-day
training led by the research team and one experienced
reviewer. During this training, the definitions, study pro-
tocol, adjusted review form and examples of AEs will be
discussed. The reviewers will also receive a review man-
ual. They will be compensated for their review activities
at an hourly rate for expenses. During the review pro-
cess the reviewers can ask advice from a general inter-
nist about accepted clinical practice in the specialty of
internal medicine.
The records will be reviewed by one reviewer and he
determines whether complications, an adverse event or
a near miss have occurred during the index admission
to the hospital or the six months following the index
admission using a paper based structured review form.
This review form will be adapted from the Dutch
Adverse Event Study [34,39] and adjusted and specified
for this patient group. The review form starts with gen-
eral characteristics of the admission and possible com-
plications. Next, if the surgeon determines that an
adverse event is present, the review will be continued
with questions about the nature and impact, location
and involved specialty, classification, preventability and
causes of the adverse event. The last part of the review
form will be about the clarity and completeness of infor-
mation in the patient record for the transfers of the
patient between the different wards and specialties
within the hospital.
A random sample of 10% of the records will be inde-
pendently reviewed by a second reviewer to assess the
variation in the review process between reviewers.
Intervention study
Within the intervention study three different interven-
tions will be implemented in the surgical wards as
described in the study design. The three interventions
have in common that they all focus on information
transfer and communication within the care chain for
elderly hip fracture patients. The SBAR focuses on
information transfer and communication between care
professionals within the ward. The patient safety card is
aimed at providing a complete picture of the current
situation from patient to care provider. The information
leaflet is aimed at providing useful information to the
patient after discharge. In the text below each interven-
tion will be described in more detail.
Intervention A: Implementing the SBAR communication tool
(Research question 2a)
Aim To improve communication among care providers,
and for nurses to provide timely and accurate informa-
tion during contacts with the physician and in the
record keeping.
Background Previous studies have shown that a model
of structured communication can improve clinical com-
munication [22,24]. The structured communication tool
that will be used in the current study is SBAR. SBAR
stands for Situation, Background, Assessment and
Recommendation a n di sd e s i g n e dt os t r u c t u r ea n d
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provide timely and accurate information. The tool
describes the most relevant points that can be discussed
about a patient and how to effectively communicate
them during various types of contact moments between
care providers. It was developed and tested in the
United States and proved to be useful there [24]. SBAR
can be implemented in several ways, for instance using
cards, posters near the telephones in the ward, hand-off
forms and so forth to create awareness and stimulate
nurses and clinicians to actively use the tool in handoff
or clinical communication moments.
Implementation For this study the original SBAR-tool
will be translated and adapted in consultation with the
participating wards to ensure that the relevant topics are
present. These topics will be printed onto a pocketsize,
laminated card that the nurses can keep with them dur-
ing their shift. This card can be used during two differ-
ent communication moments between care providers.
On one side of the card there will be a description of
the relevant items to discuss during the morning rounds
or a telephone consult between the nurse and the physi-
cian about the condition of the patient. This side of the
SBAR tool is shown in Table 2. On the other side will
be a description of the relevant topics for a structured
and complete record keeping. The SBAR-tool will be
explained, discussed and handed over to the nurses dur-
ing a meeting to announce and explain the study. The
card will be accompanied by an example of a paper case
how to use the SBAR-tool. Nurses will be asked to keep
the card with them during their shift so that they have
easy access to it and to use the card when consulting a
physician or during the morning rounds. Since the
SBAR-tool will be given to all nurses in the intervention
wards it will apply to all hip fracture patients that are
admitted during the research period.
Evaluation The first step is to determine to what
extend and under what circumstances the SBAR tool is
used by the nurses. We consider the implementation
successful when 60% of the nurses uses the SBAR
structure during communication moments. The use
and possible effectiveness of the SBAR will be evalu-
ated with different methods. First, short interviews will
be conducted with some of the nurses of the interven-
tion wards to discuss the possible added value, reasons
for using or not using the instrument and possible
improvements in the instrument or implementation for
the future. Second, during the research period, obser-
vations of the morning rounds will be conducted on a
regular base, approximately once a month. During
these observations the process and content of commu-
nication and information transfer between nurse and
physician during the morning rounds will be observed.
Also, for each individual patient, it will be observed
whether the different relevant topics of the SBAR-com-
munication tool are discussed or mentioned. These
aspects are, when applicable: current situation of the
patient, special circumstances, possible risks, required
actions, timing of the actions, reporting back, and
finally, is the structure of the SBAR being used. The
third evaluation moment is during the retrospective
patient record review of the included patients. Here,
the completeness and transfer of information in the
patient record will be reviewed.
Intervention B: Involving patients and their families
(Research question 2b)
Aim To involve patients more actively in their own care
process.
Background The second intervention consists of a card
with advice for patients about how to get more actively
involved in the care process. The card was developed by
the Federation of Patients and Consumer Organisations
in the Netherlands (NPCF). This patient safety card pro-
vides patients with short instructions and graphical
images for several topics to discuss with care providers
that might be relevant for the safety of their care pro-
cess. These instructions are in short:
￿ Give all information to the care providers about
your state of health;
￿ Ask the care provider when something is not clear
to you;
￿ Discuss the surgical procedure with the care
provider;
￿ Write down an overview of your medication use;
￿ Ask questions when your medication looks differ-
ent from expected;
￿ Follow the instructions given by your care
provider.
Implementation Within the research programme, half
of the included patients in the intervention wards will
receive the patient safety card. The card will be given to
the patients during the hospital admission with a short
instruction on how to use the card.
Evaluation The implementation and effectiveness of the
patient safety card will be established during an inter-
view by telephone with the patient two weeks after dis-
charge. We will consider the patient safety card
successful when 60% of the patients has used the card
and found it useful. One of the topics in the interview is
therefore about the use and possible added value of the
patient safety card and the need and possibility for
patients and their family to get actively involved. Also,
the possible consequences of the use of the patient
safety card on the patients’ trust in health care are dis-
cussed during these interviews. Finally, during the retro-
spective patient record review six months after
discharge the number of complications and adverse
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measurement.
Intervention C: Reducing avoidable harm after discharge
(Research question 2c)
Aim To provide the patient with information and to
reduce avoidable harm after discharge, such as adverse
medication events, pneumonia, urinary tract infections,
wound infections, delirium, falls and pressure ulcers.
Background The intervention consists of standardised
information using an information leaflet with “bundles”
for the patient after discharge. The concept of “bundles”
was developed and tested by the Institute of Healthcare
Improvement in Boston [40]. A bundle is a structured
way of improving the processes of care and patient out-
comes. It involves a small straightforward set of prac-
tices that have been shown to improve patient
outcomes. The recommendations in the “bundles’ for
the period after discharge are evidence based best prac-
tices [41]. Bundles were originally developed for use by
health care professionals, in our study we aim to adapt
this concept for use by patients after discharge. The evi-
dence based best practices will be reformulated to make
them understandable and usable for patients and they
will be printed into an information leaflet. The following
topics will be described in the leaflet:
￿ Contact information;
￿ Exercise recommendations;
￿ Medication use;
￿ Problems with the operation wound;
￿ Thrombosis;
￿ Pressure wounds;
￿ Urinary tract infection;
￿ Fall prevention;
￿ Delirium.
Implementation In the intervention wards 50% of the
included patients will receive the leaflet with instruc-
tions. For each included patient a short questionnaire
about the health status before discharge will be filled
out to determine for which complications a patient may
be at increased risk. The chapters concerning these
complications are checked in the leaflet to indicate the
most relevant information for each specific patient.
Evaluation The use of the leaflet will be evaluated by
asking the patient about the added value and the usabil-
ity of the bundles during a short interview by telephone
two weeks after discharge. We will consider the leaflet
useful if 60% of the patients says they have used the
leaflet and found it useful. The effect of the bundles will
be evaluated during the telephone interview two weeks
after discharge and by measuring avoidable harm (e.g.
adverse medication events, urinary tract infections,
wound infections, delirium, falls and pressure ulcers)
within 6 months after discharge. The patient will be
called again around 6 months after discharge to ask
about any medical problems occurring after discharge
and their recovery in the past six months. Also, the
patient records of all included patients will be reviewed
Table 2 Description of the SBAR communication tool
Identify yourself (name, function). Do you have the information below available?
S Situation
Situation of the patient you are calling about:
￿ State name, department and room number of patient
￿ Give a short overview of the problem and state when you visited the patient
B Background
Relevant information about the background can include the following:
￿ Date of admission and admission diagnosis
￿ Date of surgery, wound status and information about drains
￿ Lab results and most recent vital signs. Is the patient using oxygen?
￿ Medication overview, allergies, IV fluids
￿ Other relevant clinical information
￿ Mental status of the patient (delirium?)
￿ Code status
A Assessment
What is your assessment of the situation of the patient?
R Recommendation
What is your recommendation for this situation, examples:
￿ Come and see the patient as soon as possible
￿ What actions should be taken when the situation changes?
Write down the comment of the physician in the patient record and changes in the condition of the patient.
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about possible complications and avoidable harm after
discharge.
Outcome measures
T h ep r i m a r yo u t c o m em e a s u r e si nt h i ss t u d ya r et h e
incidence of complications and adverse events, mortality
rate within six months after discharge and functional
mobility six months after discharge. Secondary outcome
measures are length of hospital stay, quality and com-
pleteness of information transfer and patient satisfaction
with the instruments.
General data collection and follow up
After receiving informed consent a questionnaire will be
filled out with patient characteristics and the pre-frac-
ture status of the patient. Information about the status
before the fracture will be gathered using the 10-item
modified Barthel Index for ADL-functioning [42], the
Parker and Palmer pre-fracture mobility score [43],
the Short Nutritional Assessment Questionnaire [44]
and the Delirium Observation Screening Scale [45]. In
addition, information will be gathered about the home
situation before admission. Before discharge, the ques-
tionnaire will be completed with information about the
o c c u r r e n c eo fp r e s s u r ew o u n d s, delirium, urinary tract
infections, wound infections, falls during admission
and possible risk factors after discharge for these
complications.
All included patients will be followed for a period of
six months after discharge. During this period two inter-
views by telephone will be held with all included
patients, two weeks and six months after discharge. Dur-
ing these interviews patients will be asked some multiple
choice questions about their current residence, physical
functioning, use of health care, the occurrence of unex-
pected events and some open end questions about their
experiences during the whole care process. In addition
to these interviews, the retrospective patient record
review study will be conducted to review the patient
record up to six months after discharge. The methods
of this record review study will be identical to the base-
line measurement described earlier. Again, the reviewers
will look for complications, adverse events, the quality
of record keeping and written information for the trans-
fers of the patient between the different hospital wards.
This second record review stu d yw i l lb eu s e dt oa s s e s s
the effect of the complete intervention programme on
the possible reduction in complications and adverse
events.
Power calculation
We expect to reduce the absolute risk of suffering from
ac o m p l i c a t i o nb y5 %b yi m p l e m e n t i n gt h ei n t e r v e n t i o n
programme, with a standard deviation of 10%. With an
alpha of 0.05 and a power of 80% there should be 64
participants in every intervention group and in the con-
trol group. The aim is to include 80 patients into every
intervention group to compensate for possible drop-out
during the follow-up phase of the study. The total num-
ber of patients included in the four different interven-
tion groups will then be 320. In addition, 80 patients
will be included into the control group.
Data analysis
The data will be analysed using Stata 10.1 for Windows.
During the data collection regular data checks (identify
out-of-range answers, inconsistent responses and miss-
ing data) will be performed.
In the evaluation of the effectiveness of the interven-
tion programme all analyses will be performed at patient
and group level. The data will be analysed using the
intention-to-treat principle. This means that patients
will remain in the group to which they were randomly
allocated at baseline. The patient characteristics will be
compared for all groups and, if necessary, we will cor-
rect for differences.
The determination of complications is based on the
complication registration of the Dutch Society of Medi-
cal Specialists (in Dutch: Orde van Medisch Specialis-
ten). The determination of adverse events is based on
three criteria; 1) an unintended (physical and/or mental)
injury which 2) results in temporary or permanent dis-
ability, death or prolongation of hospital stay, and is 3)
caused by health care management rather than the
patient’s disease. To determine whether the injury is
caused by health care a six-point scale will be used, cau-
sation scores of 4-6 will be classified as adverse events.
The preventability of the adverse events will also be
measured on a six-point scale, scores of 4-6 will be clas-
sified as preventable adverse events. The incidence and
mean number of complications and adverse events will
be calculated.
The inter-rater reliability of the review process will be
expressed as a kappa statistic. This kappa statistic will
be calculated for the determination of the presence or
absence of complications and adverse events. The
records from the reliability study will be used for this
analysis, they represent up to 10% of all reviewed patient
records.
Discussion
Strengths and limitations of the study
One of the strengths of this study is the integrated
intervention programme that will be implemented in
three surgical wards. All three interventions are aimed
at improving a different aspect of the care for elderly
hip fracture patients. This approach may have more
Merten et al. BMC Health Services Research 2011, 11:59
http://www.biomedcentral.com/1472-6963/11/59
Page 9 of 12impact than implementing three separate interventions
in different situations and could increase the possibility
of finding measurable effects in patient outcomes. The
randomisation at patient level reduces the influence of
the differences between the three wards. In every parti-
cipating ward the included patients should be equally
distributed over the four intervention groups. Another
important aspect of this intervention programme is that
it focuses on one specific patient group that will
increase in the future. The baseline measurement will
give insight into the complications and adverse events
that affect this patient group. This information will pro-
vide valuable insights and possibilities for improving
patient safety. Finally, the follow-up of six months
enables us to assess the functional recovery of patients
and their experiences during those months. These
experiences can be used to improve the care after dis-
charge for this patient group and to explore the possibi-
lities for care that is more adapted to their needs.
The study also has some limitations. First, although
the results of previous studies showed that the instru-
ments used in retrospective record review studies are
sensitive for identifying adverse events [46,47], there are
some important factors that have to be considered. The
retrospective patient record review method relies exclu-
sively on the information available in the hospital
patient record, this can be insufficient for adverse event
determination [13,48]. Also, adverse events revealed
after discharge are only found if they result in a read-
mission or if it is recorded in the outpatient record of
the patient. The hospital record is not always complete
with the risk of missing important information. A gen-
eral possible weakness in retrospective review studies is
hindsight bias [49]. Knowing the outcome and its sever-
ity may influence judgement of causation and prevent-
ability. A second limitation of the study is that elderly
hip fracture patients suffering from dementia cannot be
included into the study due to practical and ethical rea-
sons, which may lead to an underestimation of the
experienced problems and therefore the possible effects
of the interventions. Some other issues that might influ-
ence the outcomes in this trial are the randomisation
process, the blinding of patients and the possible effect
of the presence of the researcher in the intervention
wards. It was mentioned before that randomisation will
be on patient level. It is possible that two patients in the
same room receive different interventions and expose
each other to the interventions. Another possible source
of bias is that patients cannot be blinded, they are auto-
matically aware of the intervention group that they will
be in as they immediately receive the interventions after
inclusion. A third issue is the presence of the research-
ers on the wards on a regular basis for the observations.
O n c eam o n t ht h em o r n i n gr o unds will be observed to
assess the effectiveness of the SBAR communication
tool, this in itself can increase the use of the tool.
Feasibility
The feasibility of the study depends on a number of fac-
tors. First, we are relying on the nurses to include the
patients into the trial as they are the first to know when
an eligible patient is admitted to the ward. This way, the
inclusion can take place as soon as possible after admis-
sion. After a few weeks it will become clear whether this
method works or not. If the patients are not included by
the nurses, the researchers will take over the inclusion
process. Second, the success of the intervention pro-
gramme will depend on the number of available
patients, their decision to participate and the loss to
follow-up.
Relevance of the study
The increasing incidence of hip fractures in vulnerable
elderly patients in combination with the complex care
process they have to go through, with the risks of sub-
optimal communication and unintended events, all con-
tribute to the relevance of this study. This study not
only aims to improve clinical communication between
care providers and involve the patient more in their
own care process but will also generate more knowledge
and insight into the nature of adverse events and avoid-
able harm for this patient group. The combined use of
three interventions for improving patient safety in this
patient group is an innovative aspect of this study.
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